Gene therapy may increase cancer cure rates, medical physicists show

August 13, 2002

Richmond, VA (August 13, 2002)--An innovative combination of two medical procedures-gene therapy and radiation therapy--can increase cancer cure rates by significant amounts compared to the cure rates offered by conventional radiation therapy alone, a Virginia Commonwealth University (VCU) team has concluded. The researchers presented their results last month in Montreal at the annual conference of the American Association of Physicists in Medicine.

Known as genetic radiotherapy, the combined treatment can potentially increase cancer cure rates by up to 70% over present therapies that exclusively use radiation therapy, the researchers say. The combined technique is currently evolving from laboratory studies to human clinical trials.

In genetic radiotherapy, cancer cells are infected with a virus that makes tumor cells more sensitive to--and more easily destroyed by--radiation such as x-rays. At last month's medical physics meeting, the VCU researchers presented a quantitative model predicting the increase in cancer cure rates with genetic radiotherapy.

"Our model incorporates human patient data from large radiotherapy clinical trials as well as experimental genetic therapy data from laboratory work," says Dr. Paul Keall, an assistant professor in VCU's radiation oncology department.

To calculate the projected cure rates, the group considers the fraction of tumor cells that are genetically modified, or "transduced," by the injected virus. They also consider the sensitivity of the genetically transformed cells to radiation.

With present laboratory technology, the researchers predict an increase in cure rate of 15% when genetic radiotherapy is used instead of conventional radiation treatments on non-genetically-altered cancer cells. Exploring an ideal situation in which all of the cancer cells are genetically modified, they find the technique can theoretically increase the cancer cure rate by as much as 70%. In their model, a "cure" means a lack of tumor recurrence at the site where the tumor was treated.

"Thus, our results indicate that genetic radiotherapy has the potential to significantly improve cancer cure rates compared to current radiotherapy practices," says Keall. "Needed now are carefully controlled studies to test our predictions."
-end-
Meeting paper: "Radiobiological Predictions for Genetically Radiosensitized Tumors," by Paul Keall, PhD Guido Lammering, MD, Theodore Chung, MD, and Rupert Schmidt-Ullrich, MD, all at Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA, paper MO-E-517B-7, Monday, July 15, 2002, 44th Annual AAPM Meeting, Montreal, Quebec.

American Institute of Physics

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.